Jefferies Maintains a 'Buy' on CVS Caremark (CVS); A Superior Model
CVS Hot Sheet
Rating Summary:7 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 11 | New: 38
Jefferies maintains a 'Buy' on CVS Caremark (NYSE: CVS) price target raised from $47 to $50.
Jefferies analyst says, "While it has taken longer and been rockier than expected, the promise of the vertically integrated CVS Caremark is finally starting to be realized. The company’s significant competitive advantage of an integrated platform, demonstrated in offerings such as Pharmacy Advisor and Maintenance Choice, is leading to market share gains in both its retail and PBM operations. We believe this will prove increasingly disruptive to competitors."
"We are establishing 1Q12 EPS estimate of $0.63 and increasing our FY12 and FY13 estimates to $3.24 and $3.55 from $3.21 and $3.50. A good chunk of the improvement, but not all, is due to the business flowing from Walgreens (NYSE: WAG)."
For an analyst ratings summary and ratings history on CVS Caremark click here. For more ratings news on CVS Caremark click here.
Shares of CVS Caremark closed at $43.00 yesterday, with a 52 week range of $31.30-$44.09.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Jefferies analyst says, "While it has taken longer and been rockier than expected, the promise of the vertically integrated CVS Caremark is finally starting to be realized. The company’s significant competitive advantage of an integrated platform, demonstrated in offerings such as Pharmacy Advisor and Maintenance Choice, is leading to market share gains in both its retail and PBM operations. We believe this will prove increasingly disruptive to competitors."
"We are establishing 1Q12 EPS estimate of $0.63 and increasing our FY12 and FY13 estimates to $3.24 and $3.55 from $3.21 and $3.50. A good chunk of the improvement, but not all, is due to the business flowing from Walgreens (NYSE: WAG)."
For an analyst ratings summary and ratings history on CVS Caremark click here. For more ratings news on CVS Caremark click here.
Shares of CVS Caremark closed at $43.00 yesterday, with a 52 week range of $31.30-$44.09.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Barclays Attends Total System Services' (TSS) Analyst Day: Three Signs For Additional Upside
- Barclays Maintains an 'Equalweight' on J. C. Penney (JCP); Slashing PT on Disappointing Results
- Barclays Raises Estimates on Williams-Sonoma (WSM); Encouraging Q1 Results
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
